CJC-1295 + Ipamorelin 10 mg Blend: Dosage Guide – Page 2

Sermorelin and ipamorelin are popular peptide therapies used to stimulate growth hormone release in a more natural way than direct GH injections. A common approach for patients who want to combine different stimulants is to blend CJC-1295 (also known as Sustamar) with Ipamorelin, especially when the goal is to maximize secretion while minimizing side effects. The typical blend that clinicians and experienced users recommend involves a 10 mg vial of CJC-1295 per week, mixed with a 1 mg vial of ipamorelin, then diluted in a suitable solvent such as bacteriostatic water or saline. Once the mixture is prepared, the total volume is usually around 2 ml, giving each milligram of CJC-1295 a dilution factor that keeps the final concentration within the therapeutic range.

A standard dosage schedule for this blend is to inject 0.5 ml (containing approximately 2.5 mg of CJC-1295 and 0.25 mg of ipamorelin) subcutaneously twice daily, typically before breakfast and before bedtime. Some patients prefer a once-daily dose of 1 ml, which delivers roughly double the amount per injection but may be less convenient for those who want to spread stimulation throughout the day. The total weekly dose then ranges from 35 mg to 70 mg of CJC-1295, depending on the chosen frequency and volume. Ipamorelin is delivered in proportion to keep the ratio consistent with the CJC-1295 dosage; thus, a 10 mg vial of ipamorelin can support up to 20–30 injections per week at a typical 0.25 mg dose per injection.

When adding HCG (human chorionic gonadotropin) to this protocol, many users employ an HCG Mixing Protocol Calculator to determine the precise amount of hormone needed for each session. The calculator typically requires input such as the desired total daily dose of HCG (often measured in international units), the volume of solvent being used, and any dilution constraints set by the pharmacy or supplier. For example, if a patient wants 500 IU of HCG per day and plans to inject 0.5 ml at each session, the calculator will output that they need 1000 IU/ml concentration in their final solution. The user can then mix 500 IU of HCG with an appropriate volume of solvent (e.g., 5 ml) and add this to the existing peptide blend or administer it separately.

The HCG Mixing Protocol Calculator also helps adjust for variations in vial size, such as 10 IU or 250 IU vials. By entering the exact number of vials available, the calculator can suggest how many vials to use per injection and whether any reconstitution steps are necessary. It will also account for the stability of HCG when stored at 4 °C versus room temperature, ensuring that each dose remains potent throughout the treatment cycle.

For users looking to optimize results, a typical search strategy involves querying terms like “CJC-1295 ipamorelin blend dosage” or “HCG mixing protocol calculator” in reputable medical forums and peptide supplier websites. Many sites offer downloadable spreadsheets where you can input your weight, desired GH peak, and the number of injections per day; these tools will then generate a personalized dosing schedule. It is also useful to review clinical studies that examine the pharmacodynamics of CJC-1295 combined with ipamorelin, as these provide evidence for dose–response relationships and help refine protocols based on individual response.

In summary, a standard protocol for a CJC-1295/ipamorelin blend at 10 mg per week involves preparing a 2 ml solution containing both peptides, injecting 0.5 ml twice daily or 1 ml once daily. Adding HCG requires calculating the exact IU needed using an HCG Mixing Protocol Calculator to ensure precise dosing and stability. Patients often refine these parameters through targeted searches of clinical literature and community forums, adjusting for body weight, age, and desired therapeutic outcomes.